Sun Pharmaceutical board to consider ₹15,000 crore NCD issue on October 12

Sun Pharma’s board will consider an NCD issue of up to ₹15,000 crore on October 12. The debentures are proposed to be issued through private placement in one or more tranches.

MediaNews muestra el titular y el resumen publicados por el medio. El artículo completo se lee en el sitio del editor. (www.cnbctv18.com)